NEOCINE Trademark

Trademark Overview


On Monday, September 30, 2024, a trademark application was filed for NEOCINE with the United States Patent and Trademark Office. The USPTO has given the NEOCINE trademark a serial number of 98777335. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 13, 2025. This trademark is owned by NeoCine Therapeutics Inc.. The NEOCINE trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable computer software for the identification and analysis of neoepitopes that control tumors in vivo; downloadable computer software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; downloadable bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies

Pharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products and personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control

Medical analysis services for the treatment of cancer and the identification and analysis of neoepitopes that control tumors in vivo; medical services, namely, providing therapies for treating cancer; medical testing and medical diagnostic services for processing cancer and normal protein sets to identify high-quality patient-specific neoepitopes for personalized cancer vaccine development; preparation and dispensing of personalized immunotherapies and neoepitope-based cancer vaccines tailored to individual patient profiles

Scientific research and development in the field of oncology, specifically focused on identifying and analyzing neoepitopes that control tumors in vivo for the development of personalized cancer vaccines; medical and scientific research related to the processing of cancer and normal protein sets, identification of high-quality patient-specific neoepitopes, and design of immunotherapeutic treatments; providing temporary use of non-downloadable software for the prediction of neoepitope immunogenicity and the design of targeted cancer vaccines
neocine

General Information


Serial Number98777335
Word MarkNEOCINE
Filing DateMonday, September 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2025

Trademark Statements


Goods and ServicesDownloadable computer software for the identification and analysis of neoepitopes that control tumors in vivo; downloadable computer software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; downloadable bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products and personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control
Goods and ServicesMedical analysis services for the treatment of cancer and the identification and analysis of neoepitopes that control tumors in vivo; medical services, namely, providing therapies for treating cancer; medical testing and medical diagnostic services for processing cancer and normal protein sets to identify high-quality patient-specific neoepitopes for personalized cancer vaccine development; preparation and dispensing of personalized immunotherapies and neoepitope-based cancer vaccines tailored to individual patient profiles
Goods and ServicesScientific research and development in the field of oncology, specifically focused on identifying and analyzing neoepitopes that control tumors in vivo for the development of personalized cancer vaccines; medical and scientific research related to the processing of cancer and normal protein sets, identification of high-quality patient-specific neoepitopes, and design of immunotherapeutic treatments; providing temporary use of non-downloadable software for the prediction of neoepitope immunogenicity and the design of targeted cancer vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeoCine Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803

Party NameNeoCine Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803

Trademark Events


Event DateEvent Description
Monday, September 30, 2024NEW APPLICATION ENTERED
Thursday, April 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 4, 2025ASSIGNED TO EXAMINER
Thursday, April 10, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, April 10, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, April 10, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, April 10, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 7, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 13, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 13, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED